Citation: F. Mentre et al., Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children, J PHARMA PH, 28(3), 2001, pp. 299-319
Authors:
Lechat, P
Lardoux, H
Mallet, A
Sanchez, P
Derumeaux, G
Lecompte, T
Maillard, L
Mas, JL
Mentre, F
Pousset, F
Lacomblez, I
Pisica, G
Solbes-Latourette, S
Raynaud, P
Chaumet-Riffaud, P
Citation: P. Lechat et al., Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation - A randomized trial (fluindione, fibrillation auriculaire, aspirin et contraste spontane; FFAACS), CEREB DIS, 12(3), 2001, pp. 245-252
Citation: S. Retout et al., Development and implementation of the population Fisher information matrixfor the evaluation of population pharmacokinetic designs, COMPUT M PR, 65(2), 2001, pp. 141-151
Authors:
Bert, F
Galdbart, JO
Zarrouk, V
Le Mee, J
Durand, F
Mentre, F
Belghiti, J
Lambert-Zechovsky, N
Fantin, B
Citation: F. Bert et al., Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients, CLIN INF D, 31(5), 2000, pp. 1295-1299
Authors:
Comets, E
Pousset, F
Mentre, F
Diquet, B
Ankri, A
Mallet, A
Lechat, P
Citation: E. Comets et al., Prediction of fluindione maintenance dosage hampered by large intraindividual variability, THER DRUG M, 22(6), 2000, pp. 668-675
Authors:
Comets, E
Mentre, F
Kawai, R
Nimmerfall, F
Marbach, P
Vonderscher, J
Citation: E. Comets et al., Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits, J PHARM SCI, 89(9), 2000, pp. 1123-1133
Authors:
Deschamps, C
Dubruc, C
Mentre, F
Rosenzweig, P
Citation: C. Deschamps et al., Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model, CLIN PHARM, 68(6), 2000, pp. 647-657
Authors:
Comets, E
Mentre, F
Nimmerfall, F
Kawai, R
Mueller, I
Marbach, P
Vonderscher, J
Citation: E. Comets et al., Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR, J CONTR REL, 59(2), 1999, pp. 197-205
Citation: F. Mentre et al., Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: An application to basiliximab in renal transplantation, J PHAR BIOP, 27(2), 1999, pp. 213-230
Citation: Y. Merle et F. Mentre, Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring, J PHAR BIOP, 27(1), 1999, pp. 85-101
Authors:
Mentre, F
Golmard, JL
Launay, JM
Aubin-Brunet, V
Bouhassira, M
Jouvent, R
Citation: F. Mentre et al., Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients, PSYCHIAT R, 81(3), 1998, pp. 403-405
Citation: M. Tod et al., Robust optimal design for the estimation of hyperparameters in population pharmacokinetics, J PHAR BIOP, 26(6), 1998, pp. 689-716